Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate. - Wikidata - awgldk - TriplyDB

Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.

Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.

http://www.wikidata.org/entity/Q37873797

about

Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies Update on medical treatment for Cushing's disease.Medical management of Cushing's disease: what is the future?Recent advances in the medical treatment of Cushing's disease.Mifepristone: is there a place in the treatment of Cushing's disease?Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.PET imaging in ectopic Cushing syndrome: a systematic review.Currently used and investigational drugs for Cushing´s disease.Symptomatic Cushing's syndrome and hyperandrogenemia in a steroid cell ovarian neoplasm: a case report.Cushing's disease presenting with gastrointestinal perforation: a case report.

P2860

Q28076013-509BFEC2-7A3B-4636-84DC-009DBF0BF000 Q33802284-AD9E593A-193B-4B53-8A44-0208D7FB20B5 Q36236884-20ABA32A-0AE1-4D97-BC83-FED45C595E61 Q37621524-9371177F-1CAD-4D43-8AC0-EE7E1C4E6686 Q38063404-0A7279A2-60CA-4938-B2C6-7A19668F07A0 Q38307934-1A27170C-B940-433F-8A95-0D72BAA79A38 Q38553374-7940A8B5-AFC1-4F17-AEF6-11EAB175E6A1 Q39022297-CB15E375-D4F4-4321-A7C5-01396F9CEE18 Q41432810-DCA125A3-F58E-4BBD-9792-88DE43858370 Q41950100-016608B5-EBD4-42A5-BDFA-0D77C413C4EA

P2860

Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.

http://www.wikidata.org/entity/Q37873797

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Medical suppression of hyperco ...... ar consideration of etomidate.

@en

Medical suppression of hyperco ...... ar consideration of etomidate.

@nl

type

label

Medical suppression of hyperco ...... ar consideration of etomidate.

@en

Medical suppression of hyperco ...... ar consideration of etomidate.

@nl

prefLabel

Medical suppression of hyperco ...... ar consideration of etomidate.

@en

Medical suppression of hyperco ...... ar consideration of etomidate.

@nl

P1433

Q37873797-9253E0A7-F6F2-464D-87D2-FF5EF3FD3C59

P1476

Q37873797-7F79933D-A923-4A52-A5DF-BA9963D45D04

P2093

Q37873797-30EE266E-3CBB-4484-A86C-66D2701898C5

Q37873797-7D735ABB-CC4C-442D-BB6F-86672E320293

Q37873797-B3B153BD-2C1C-4E19-825C-019C76F67BA9

Q37873797-DE025701-A219-4C9F-A9BB-3388225311E2

P2860

Q37873797-00BF1339-5E5A-4026-B32A-B6774E69C849

Q37873797-025629EA-B199-4EC8-B823-97321997903B

Q37873797-03C65153-B0D8-4C10-BF39-1F1C30B7C25D

Q37873797-0F13ED32-B04D-4211-B074-834B07ECA5DB

Q37873797-0F6419E0-297C-48B8-91A5-00F24FE57324

Q37873797-1434166A-B689-4DA6-AE23-494FFC6CBF5F

Q37873797-155A9334-22E8-4EB3-B752-30131951D869

Q37873797-1E412D76-BC37-4936-A845-2322FB334AB3

Q37873797-1F8CDAF0-A0BB-4C18-93E8-60EFAA1EC748

Q37873797-29A7B49E-D625-4048-833D-0BB60CE7158F

P2888

Q37873797-F9163840-079E-473D-9096-D62C9499243E

P304

Q37873797-901EE65F-38A7-4251-9736-BF0888F5D4FD

P31

Q37873797-BA270B8E-3A16-49A9-97D2-548D650D1DB2

P356

Q37873797-913DD90F-3026-4942-A322-D199ECE9CDEF

P433

Q37873797-E58E74C7-A1D1-4FE5-A6FE-AFEB3A761F37

P478

Q37873797-B8F274B4-A671-4A27-A06A-713BDB44573C

P50

Q37873797-46FD5096-7A93-4FE0-BD64-AF70EDBF0B27

P577

Q37873797-12187F99-9C44-4086-9893-26FAD34187EF

P698

Q37873797-71BA6DA1-C618-4DB1-874B-3717161A287E

P356

S11102-011-0314-3

P1433

P1476

Medical suppression of hyperco ...... lar consideration of etomidate

@en

P2093

Carolin Geiger

http://www.w3.org/2001/XMLSchema#string

Florian Weis

http://www.w3.org/2001/XMLSchema#string

Jens Heyn

http://www.w3.org/2001/XMLSchema#string

Josef Briegel

http://www.w3.org/2001/XMLSchema#string

P2860

Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes

Incidence and late prognosis of cushing's syndrome: a population-based study.

A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.

Pharmacological management of Cushing's syndrome: an update.

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Medical therapy of Cushing's disease.

Acute adrenal insufficiency after a single dose of etomidate.

Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience.

Surgery for Cushing's syndrome: an historical review and recent ten-year experience.

A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood.

P2888

s11102-011-0314-3

P304

117-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11102-011-0314-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Ludwig Christian Hinske

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21556813

http://www.w3.org/2001/XMLSchema#string